ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
PharmX Technologies Limited

PharmX Technologies Limited (PHX)

0.08
0.002
(2.56%)
마감 27 1월 2:00PM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
0.08
매수가
0.079
매도가
0.08
거래량
784,479
0.079 일간 변동폭 0.08
0.012 52주 범위 0.085
market_cap
전일 종가
0.078
개장가
0.08
최근 거래 시간
25000
@
0.08
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
786,679
발행 주식
598,506,789
배당수익률
-
주가수익률
-26.67
주당순이익(EPS)
-0
매출
9.06M
순이익
-1.77M

PharmX Technologies Limited 정보

섹터
Prepackaged Software
산업
Prepackaged Software
웹사이트
본부
Sydney, New South Wales, Aus
설립됨
-
PharmX Technologies Limited is listed in the Prepackaged Software sector of the 호주 증권거래소 with ticker PHX. The last closing price for PharmX Technologies was AUD0.08. Over the last year, PharmX Technologies shares have traded in a share price range of AUD 0.012 to AUD 0.085.

PharmX Technologies currently has 598,506,789 shares in issue. The market capitalisation of PharmX Technologies is AUD46.68 million. PharmX Technologies has a price to earnings ratio (PE ratio) of -26.67.

PHX 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0045.263157894740.0760.080.0756461010.07622658DE
40.0079.589041095890.0730.0850.074143760.07739194DE
120.03681.81818181820.0440.0850.0417866790.06567874DE
260.02956.8627450980.0510.0850.0277443180.05271436DE
520.044122.2222222220.0360.0850.0126886650.04648798DE
1560.03577.77777777780.0450.0850.0125940860.0462439DE
2600.03577.77777777780.0450.0850.0125940860.0462439DE

PHX - Frequently Asked Questions (FAQ)

What is the current PharmX Technologies share price?
The current share price of PharmX Technologies is AUD 0.08
How many PharmX Technologies shares are in issue?
PharmX Technologies has 598,506,789 shares in issue
What is the market cap of PharmX Technologies?
The market capitalisation of PharmX Technologies is AUD 46.68M
What is the 1 year trading range for PharmX Technologies share price?
PharmX Technologies has traded in the range of AUD 0.012 to AUD 0.085 during the past year
What is the PE ratio of PharmX Technologies?
The price to earnings ratio of PharmX Technologies is -26.67
What is the cash to sales ratio of PharmX Technologies?
The cash to sales ratio of PharmX Technologies is 5.3
What is the reporting currency for PharmX Technologies?
PharmX Technologies reports financial results in AUD
What is the latest annual turnover for PharmX Technologies?
The latest annual turnover of PharmX Technologies is AUD 9.06M
What is the latest annual profit for PharmX Technologies?
The latest annual profit of PharmX Technologies is AUD -1.77M
What is the registered address of PharmX Technologies?
The registered address for PharmX Technologies is LEVEL 3, 120 SUSSEX STREET, SYDNEY, NEW SOUTH WALES, 2000
What is the PharmX Technologies website address?
The website address for PharmX Technologies is www.pharmx.com.au
Which industry sector does PharmX Technologies operate in?
PharmX Technologies operates in the PREPACKAGED SOFTWARE sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CDXOACardieX Limited
AUD 0.03
(76.47%)
2.19M
AQNAquirian Limited
AUD 0.295
(63.89%)
1.08M
CUFOCuFe Ltd
AUD 0.003
(50.00%)
301k
AQDAusquest Limited
AUD 0.033
(50.00%)
54.32M
LYNLycaon Resources Ltd
AUD 0.245
(48.48%)
642.61k
RADORadiopharm Theranostics Ltd
AUD 0.002
(-50.00%)
327.64k
RPMORPM Automotive Group Limited
AUD 0.002
(-50.00%)
2.21M
NHEONoble Helium Ltd
AUD 0.001
(-50.00%)
20k
PRSOAProspech Limited
AUD 0.001
(-50.00%)
66.67k
HFYHubify Limited
AUD 0.007
(-36.36%)
13.82M
ATHOAlterity Therapeutics Limited
AUD 0.004
(0.00%)
86.56M
AQDAusquest Limited
AUD 0.033
(50.00%)
54.32M
SYASayona Mining Limited
AUD 0.023
(-4.17%)
41.31M
BTRBrightstar Resources Limited
AUD 0.021
(0.00%)
36.06M
TMKTMK Energy Ltd
AUD 0.0025
(0.00%)
32.33M
EZmoney- EZmoney- 5 분 전
T53 guess who's back !!!
Truthsocial Truthsocial 5 분 전
FO DF
RDGL
ChannelTrader ChannelTrader 5 분 전
That would solve the problem.
Golden Cross Golden Cross 6 분 전
💲 000 Stocks Can make You Rich!
Golden Cross Golden Cross 7 분 전
💲 000 Stocks Can make You Rich!
arizona1 arizona1 8 분 전
Trump Supporters Are Begging Him For Their Jobs Back

https://substackcdn.com/image/fetch/w_2250,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe1724342-3fad-42ff-b838-435b57d6caad_1125x720.jpeg

http
janice shell janice shell 9 분 전
Yes, of course. Uqora. The story of the founder, Jenna Ryan, is probably familiar to a very large number of women. Symptoms can be sort of vague, and they can change, and they can be hard to describe to a doctor. I think some kind of regime like the one they suggest makes sense. They evidently have
StayHumble StayHumble 10 분 전
perForbes Insiders CE0💹KevinLamb💹+💹Bryan Cranston wow $UBQU

https://x.com/CorporateUbqu/status/1802724359762506049
https://x.com/I_Outcomes/status/1812870363094626701

".......believe it... i'm insider too ......"
https://cdn.vo
UBQU
igotthemojo igotthemojo 10 분 전
about what i expected...i think its time for your nap little boy...
PLUG
Gmenfan Gmenfan 11 분 전
How much are second hand parachutes? And I'm being kind here.....
igotthemojo igotthemojo 11 분 전
i told you the last time you made that comment about yarn that it was stupid...and then you repeated the same nonsense...

you were DEAD WRONG then and you are DEAD WRONG now...

"And yes, we know, "this time is different"."

FINALLY you have stated somethin
KBLB
ilovetech ilovetech 12 분 전
If I were the CEO of NWBO, I would SERIOUSLY consider the block chain dividend strategy, which Danish posted about on X. That is unless LP has decided to go with a merger, for example, with a company like Revimmune to register under a new CUSP number, where both strategies have successfully squeeze
NWBO
Airfred Airfred 12 분 전
Love the idea I’ll sign

Long time reader first time writing
FNMA
Pnypnchr Pnypnchr 14 분 전
This is ihub, that will never change me.
BLTHD
Investor2014 Investor2014 14 분 전
Exactly, a correlation to actual endpoints of the trial must be established.
It also has yet to be shown to be correlated with or causative of clinical outcomes.

From there further trials would be needed, where brain atrophy reduction is confirmed correlated to cognitive and/or
AVXL
MightyX MightyX 15 분 전
Your homies allow-you to f-bomb..good show for-the public
TPTW
georgejjl georgejjl 15 분 전
Pantheon and Syntagon combined give Anavex the production process control and capacity to produce Blarcamesine for commercialization and worldwide distribution and sales.

https://patheon.com/

https://www.syntegon.com/company

Good luck and GOD bless,
AVXL
PEACHMAN PEACHMAN 15 분 전
Plenty of accurate due diligence and news available at IFUS website

https://impactfusionbrands.com/news/

IFUS STRONG
IFUS
StayHumble StayHumble 15 분 전
Update!💹FundersWait✅2Ensure $DBMM Still Trades✅idiot💹

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its regis
DBMM GTII HPIL
SHEEPWOLF SHEEPWOLF 16 분 전
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR
SHEEPWOLF SHEEPWOLF 16 분 전
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR

최근 히스토리

Delayed Upgrade Clock